InMode Ltd.

InMode Ltd. is a medical technology company that specializes in the design, development, manufacture, and marketing of minimally invasive aesthetic medical products. It is based in Yokneam, Israel, and has a presence in the United States and several other countries. The company’s proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies are used in a variety of procedures, including liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. In addition, its products are used in non-invasive medical aesthetic procedures such as permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode also designs, develops, manufactures, and markets hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.

InMode Ltd. was founded in 2008 and was formerly known as Invasix Ltd. In 2017, the company changed its name to InMode Ltd. to better reflect its mission and values. Since its founding, InMode has become a leading provider of medical aesthetic products and services and has been recognized for its commitment to excellence and innovation. The company has received numerous awards and accolades, including the 2019 Frost & Sullivan Technology Leadership Award, the 2019 Aesthetic Everything Aesthetic and Cosmetic Medicine Award, and the 2019 Frost & Sullivan Best Practices Award. InMode Ltd. has also been featured in several industry-leading publications, such as The Wall Street Journal, Forbes, and The New York Times.